Circulating lncRNAs associated with occurrence of colorectal cancer progression

American Journal of Cancer Research

Volumn 5, Issue 7, 2015, Pages 2258-2265

  Shi, Jian ^a,b   Li, Xiaohua ^a   Zhang, Fan ^b   Zhang, Changxi ^b   Guan, Qinghai ^b   Cao, Xuefeng ^b   Zhu, Wentao ^b   Zhang, Xingyuan ^b   Cheng, Yu ^b   Ou, Kun ^b   Chen, Qiangpu ^b   Hu, Sanyuan ^a  

^a BINZHOU MEDICAL UNIVERSITY HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Biomarker; CRC; High throughput; lncRNA; Risk score function

Indexed keywords

LONG UNTRANSLATED RNA;

ADULT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC MARKER; GENETIC RISK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; RNA GENE; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TISSUE DISTRIBUTION; UPREGULATION; VALIDATION STUDY;

EID: 85006225995     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weren RD, Ligtenberg MJ, Kets CM, de Voer RM, Verwiel ET, Spruijt L, van Zelst-Stams WA, Jongmans MC, Gilissen C, Hehir-Kwa JY, Hoischen A, Shendure J, Boyle EA, Kamping EJ, Nagtegaal ID, Tops BB, Nagengast FM, Geurts van Kessel A, van Krieken JH, Kuiper RP and Hoogerbrugge N. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 2015; 47: 668-71.
2. Tu HC, Schwitalla S, Qian Z, LaPier GS, Yermalovich A, Ku YC, Chen SC, Viswanathan SR, Zhu H, Nishihara R, Inamura K, Kim SA, Morikawa T, Mima K, Sukawa Y, Yang J, Meredith G, Fuchs CS, Ogino S and Daley GQ. LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans. Genes Dev 2015; 29: 1074-86.
3. Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G, Buscarino M, Isella C, Lamba S, Martinoglio B, Veronese S, Siena S, Sartore-Bianchi A, Beccuti M, Mottolese M, Linnebacher M, Cordero F, Di Nicolantonio F and Bardelli A. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nat Commun 2015; 6: 7002.
4. Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W, Jarvik GP and Veenstra DL. Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis. J Clin Oncol 2015; 33: 2084-91.
5. Azvolinsky A. Colorectal cancer: to stack or sequence therapy? J Natl Cancer Inst 2015; 107.
6. Bazzocco S, Andretta E, Rodrigues P, Garrido M, Alazzouzi H, Chionh F, Carton-Garcia F, Macaya I, Nieto R, Sanchez A, Schwartz S Jr, Dopeso H, Bilic J, Mariadason JM and Arango D. Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. Clin Cancer Res 2015; [Epub ahead of print].
7. Aravalli RN and Steer CJ. Circulating microRNAs: novel biomarkers for early detection of colorectal cancer. Transl Res 2015; [Epub ahead of print].
8. Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, van Bodegraven AA, Jansen JM, Mahmmod N, Kremer W, Siersema PD and Oldenburg B. Incidence of interval colorectal cancer among inflammatory bowel disease patients undergoing regular colonoscopic surveillance. Clin Gastroenterol Hepatol 2015; [Epub ahead of print].
9. Romaguera D, Ward H, Wark PA, Vergnaud AC, Peeters PH, van Gils CH, Ferrari P, Fedirko V, Jenab M, Boutron-Ruault MC, Dossus L, Dartois L, Hansen CP, Dahm CC, Buckland G, Sanchez MJ, Dorronsoro M, Navarro C, Barricarte A, Key TJ, Trichopoulou A, Tsironis C, Lagiou P, Masala G, Pala V, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Ohlsson B, Jirstrom K, Wennberg M, Nilsson LM, Weiderpass E, Kuhn T, Katzke V, Khaw KT, Wareham NJ, Tjonneland A, Boeing H, Quiros JR, Gunter MJ, Riboli E and Norat T. Pre-diagnostic concordance with the WCRF/ AICR guidelines and survival in European colorectal cancer patients: a cohort study. BMC Med 2015; 13: 107.
10. Tang J, Zhuo H, Zhang X, Jiang R, Ji J, Deng L, Qian X, Zhang F and Sun B. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis 2014; 5: e1549.
11. Dong S, Qu X, Li W, Zhong X, Li P, Yang S, Chen X, Shao M and Zhang L. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitorresistant lung adenocarcinoma cells with widetype EGFR via downregulation of the IGF-1R expression. J Hematol Oncol 2015; 8: 43.
12. Kurian L, Aguirre A, Sancho-Martinez I, Benner C, Hishida T, Nguyen TB, Reddy P, Nivet E, Krause MN, Nelles DA, Esteban CR, Campistol JM, Yeo GW and Izpisua Belmonte JC. Identification of Novel Long Noncoding RNAs Underlying Vertebrate Cardiovascular Development. Circulation 2015; 131: 1278-1290.
13. Lorenzen JM, Schauerte C, Kielstein JT, Hubner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R, Kumarswamy R, Hafer C, Haller H, Fliser D and Thum T. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin Chem 2015; 61: 191-201.
14. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer 2015; 14: 3.
15. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS and Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
16. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A and Galandiuk S. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg 2013; 258: 400-408.
17. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J and Galandiuk S. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 2012; 256: 544-551.
18. Perilli L, Vicentini C, Agostini M, Pizzini S, Pizzi M, D'Angelo E, Bortoluzzi S, Mandruzzato S, Mammano E, Rugge M, Nitti D, Scarpa A, Fassan M and Zanovello P. Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression. Oncotarget 2014; 5: 6611-6619.
19. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, Castells A and Gironella M. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol 2013; 11: 681-688 e683.
20. Uchida S and Dimmeler S. Long noncoding RNAs in cardiovascular diseases. Circ Res 2015; 116: 737-750.
21. Tang J, Jiang R, Deng L, Zhang X, Wang K and Sun B. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget 2015; 6: 4505-4515.